Menu
 
Research menu
Jump to menu

Publications:  Ms Julia Gutjahr

Szenes E, Härzschel A, Decker S, Tissino E, Pischeli J, Gutjahr JC, Kissel S, Pennisi S et al.(2020). TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia. Leukemia
10.1038/s41375-020-0759-3
Gutjahr JC, Szenes E, Tschech L, Asslaber D, Schlederer M, Roos S, Yu X, Girbl T et al.(2018). Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia. Blood vol. 131, (12) 1337-1349.
10.1182/blood-2017-08-802462
Tissino E, Benedetti D, Herman SEM, ten Hacken E, Ahn IE, Chaffee KG, Rossi FM, Bo MD et al.(2018). Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. Journal of Experimental Medicine vol. 215, (2) 681-697.
10.1084/jem.20171288
Roos S, Schlederer M, Hartmann T, Gutjahr JC, Szenes E, Tschech L, Girbl T, Greil R et al. (2017). CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation. LEUKEMIA & LYMPHOMA. vol. 58, 41-42.
Catakovic K, Gassner FJ, Ratswohl C, Zaborsky N, Rebhandl S, Schubert M, Steiner M, Gutjahr JC et al.(2017). TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. OncoImmunology
10.1080/2162402X.2017.1371399
Tissino E, Benedetti D, Herman SE, ten Hacken E, Ahn IE, Chaffee KG, Rossi FM, Dal Bo M et al. (2017). INSIDE-OUT VLA-4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE. HAEMATOLOGICA. vol. 102, 229-229.
Ganghammer S, Gutjahr J, Hutterer E, Krenn PW, Pucher S, Zelle-Rieser C, Johrer K, Wijtmans M et al.(2015). Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors. Haematologica vol. 101, (3) e99-e102.
10.3324/haematol.2015.133470
Gutjahr JC, Greil R, Hartmann TN(2015). The role of CD44 in the pathophysiology of chronic lymphocytic leukemia. Frontiers in Immunology vol. 6, (MAR)
10.3389/fimmu.2015.00177
Return to top